Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 150 of 1,261
  1. US 11845727

    Aldehyde and ketone derivatives of psilocybin and methods of using

    Enveric Biosciences Canada Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  2. US 11845747

    Ester and carbonate pyrimidine compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  3. US 11845752

    Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis B

    Aligos Therapeutics, Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  4. US 11845787

    DNA antibody constructs for use against HIV

    Inovio Pharmaceuticals, Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  5. US 11845778

    Prefusion PIV F immunogens and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  6. US 11844773

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  7. US 11844779

    PKC-Delta-I inhibitor formulations and uses thereof

    United States Government as represented by the Department of Veterans Affairs Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  8. US 11845726

    C4-carbonothioate-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  9. US 11845800

    Methods for treating or preventing asthma by administering an IL-4R antagonist

    REGENERON PHARMACEUTICALS, INC. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  10. US 11845989

    Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors

    REGENERON PHARMACEUTICALS, INC. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  11. US 11845722

    Deuterated compounds and uses thereof

    Aldeyra Therapeutics, Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  12. US 11844756

    Compositions and methods for treating anemia

    Akebia Therapeutics, Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  13. US 11844837

    Compositions of a polyorthoester and an organic acid excipient

    Heron Therapeutics, Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  14. US 11845965

    Regulation of gene expression using engineered nucleases

    Sangamo Therapeutics, Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  15. US 11844765

    Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

    REGENERON PHARMACEUTICALS, INC. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  16. US 11844769

    Use of cysteamine and derivatives thereof to suppress tumor metastases

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  17. US 11844830

    Vaccines for human papilloma virus and methods for using the same

    Inovio Pharmaceuticals, Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  18. US 11844771

    Methods of treating acute respiratory distress syndrome using colchicine

    INSTITUT DE CARDIOLOGIE DE MONTREAL Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  19. US 11845963

    HSD17B13 variants and uses thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  20. US 11844799

    Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic

    Actinium Phamaceuticals, Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  21. US 11844801

    Oral compositions of MK2 pathway inhibitor for treatment of immune conditions

    Aclaris Therapeutics, Inc. Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  22. US 11844816

    Compositions and methods for augmenting the nasal microbiome

    Arizona Board of Regents on Behalf of Northern Arizona University Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  23. US 11844805

    Formulations of testosterone and methods of treatment therewith

    The Board of Regents of the University of Texas System Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted
  24. US 11845959

    Identification of factor that promotes human HSC self-renewal

    The Regents of the University of California Β· Granted Dec 19, 2023 Β· Expires Dec 14, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.